Smita Shenoy
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Smita Shenoy has a total of 114 co-authors. Here are the top co-authors by number of shared publications:
- Nitesh Kumar
Department of Pharmacology and Toxicology, National Institute of Pharmaceutical Education and Research (NIPER), Hajipur, India
11 shared publications - Akshatha Ganesh Nayak
Division of Biochemistry, Department of Basic Medical Sciences, Manipal Academy of Higher Education, Manipal, Karnataka, India
4 shared publications Arul Amuthan
Division of Pharmacology, Department of Basic Medical Sciences, Manipal Academy of Higher Education, Manipal, Karnataka, 576104
4 shared publications- Maya Roche
Manipal Acad Higher Educ, Dept Biochem, Melaka Manipal Med Coll, Manipal, Karnataka, India
4 shared publications Tara Shanbhag
4 shared publicationsAmod Tilak
Department of Pharmacology, Kasturba Medical College, Manipal , Manipal Academy of Higher Education , Manipal, Karnataka , India
3 shared publications
Latest Publications
- Open Access
- 28 June 2026
- Published by Veterinary World in Veterinary World
- Vol. 19 (6) , 2650-2666
Melatonin attenuates fluoride-induced neurotoxicity and cognitive dysfunction through modulation of oxidative stress, neuroinflammation, and SIRT1 signaling in Wistar rats
Background and Aim: Chronic fluoride exposure causes neurotoxicity, oxidative stress, neuroinflammation, and cognitive impairment, posing a significant public health concern. This study investigated the neuroprotective potential of melatonin against fluoride-induced neurotoxicity and cognitive dysfunction in male and female Wistar rats, with emphasis on oxidative stress, neuroinflammation, apoptosis, and sirtuin 1 (SIRT1) signaling. Materials and Methods: Four-week-old Wistar albino rats (n=8 per group per sex) were exposed to sodium fluoride (NaF, 50 ppm in drinking water) alone or co-treated with melatonin (10 or 20 mg/kg, oral) for 8 weeks. Cognitive function was assessed using the Morris Water Maze (MWM) and Novel Object Recognition Test (NORT). Serum fluoride, brain SIRT1, oxidative stress markers (malondialdehyde [MDA], superoxide dismutase [SOD]), apoptosis markers (caspase-3, B-cell lymphoma 2 [Bcl-2]), inflammatory cytokines (tumor necrosis factor-α [TNF-α], interleukin-6 [IL-6]), acetylcholinesterase (AChE) levels, and hippocampal histopathology were evaluated. Results: NaF exposure significantly elevated serum fluoride, reduced brain SIRT1, increased oxidative stress, apoptosis, neuroinflammation, AChE activity, and caused hippocampal neuronal damage, leading to impaired learning and memory in both sexes (p < 0.05). Melatonin co-treatment (both doses) significantly attenuated these changes by lowering serum fluoride, restoring SIRT1 levels, reducing MDA, caspase-3, TNF-α, IL-6, and AChE, while increasing SOD and Bcl-2. It also improved behavioral performance in the MWM and NORT and preserved hippocampal neuronal morphology. Effects were comparable between sexes and between the two melatonin doses. Conclusion: Melatonin effectively mitigates fluoride-induced neurotoxicity and cognitive dysfunction in Wistar rats by modulating oxidative stress, neuroinflammation, apoptosis, and SIRT1 signaling. These findings highlight melatonin as a promising neuroprotective agent against environmental fluoride toxicity, with potential translational relevance for fluorosis-endemic areas. Keywords: cognitive dysfunction, fluoride neurotoxicity, melatonin, neuroinflammation, neuroprotection, oxidative stress, SIRT1, Wistar rats.
- 28 June 2026
- Published by Veterinary World in Veterinary World
- Vol. 19 (6) , 2650-2666
Open AccessMelatonin attenuates fluoride-induced neurotoxicity and cognitive dysfunction through modulation of oxidative stress, neuroinflammation, and SIRT1 signaling in Wistar rats
Background and Aim: Chronic fluoride exposure causes neurotoxicity, oxidative stress, neuroinflammation, and cognitive impairment, posing a significant public health concern. This study investigated the neuroprotective potential of melatonin against fluoride-induced neurotoxicity and cognitive dysfunction in male and female Wistar rats, with emphasis on oxidative stress, neuroinflammation, apoptosis, and sirtuin 1 (SIRT1) signaling. Materials and Methods: Four-week-old Wistar albino rats (n=8 per group per sex) were exposed to sodium fluoride (NaF, 50 ppm in drinking water) alone or co-treated with melatonin (10 or 20 mg/kg, oral) for 8 weeks. Cognitive function was assessed using the Morris Water Maze (MWM) and Novel Object Recognition Test (NORT). Serum fluoride, brain SIRT1, oxidative stress markers (malondialdehyde [MDA], superoxide dismutase [SOD]), apoptosis markers (caspase-3, B-cell lymphoma 2 [Bcl-2]), inflammatory cytokines (tumor necrosis factor-α [TNF-α], interleukin-6 [IL-6]), acetylcholinesterase (AChE) levels, and hippocampal histopathology were evaluated. Results: NaF exposure significantly elevated serum fluoride, reduced brain SIRT1, increased oxidative stress, apoptosis, neuroinflammation, AChE activity, and caused hippocampal neuronal damage, leading to impaired learning and memory in both sexes (p < 0.05). Melatonin co-treatment (both doses) significantly attenuated these changes by lowering serum fluoride, restoring SIRT1 levels, reducing MDA, caspase-3, TNF-α, IL-6, and AChE, while increasing SOD and Bcl-2. It also improved behavioral performance in the MWM and NORT and preserved hippocampal neuronal morphology. Effects were comparable between sexes and between the two melatonin doses. Conclusion: Melatonin effectively mitigates fluoride-induced neurotoxicity and cognitive dysfunction in Wistar rats by modulating oxidative stress, neuroinflammation, apoptosis, and SIRT1 signaling. These findings highlight melatonin as a promising neuroprotective agent against environmental fluoride toxicity, with potential translational relevance for fluorosis-endemic areas. Keywords: cognitive dysfunction, fluoride neurotoxicity, melatonin, neuroinflammation, neuroprotection, oxidative stress, SIRT1, Wistar rats.
- Open Access
- 28 May 2026
- Published by Springer Nature in Cancer Chemotherapy and Pharmacology
- Vol. 96 (1) , 58
Antibody–drug conjugates in colorectal cancer: molecular design, preclinical advances, and translational challenges
Colorectal cancer (CRC) remains a leading cause of cancer-related morbidity and mortality worldwide, largely because of tumor heterogeneity, therapeutic resistance, and the limited efficacy of existing targeted therapies in advanced disease. Antibody–drug conjugates (ADCs) have emerged as a promising class of targeted anticancer therapeutics that combine the specificity of monoclonal antibodies with the cytotoxic potency of highly active payloads, thereby enabling selective tumor cell killing while minimizing systemic toxicity. Although ADCs have demonstrated substantial clinical success in several solid and hematological malignancies, their translation to CRC has been relatively limited, underscoring the need for a focused evaluation of CRC-specific ADC development. This review provides a comprehensive and critical overview of recent advances in ADC design and preclinical development for CRC, with emphasis on molecular architecture, linker–payload chemistry, antigen selection, and pharmacological mechanisms of action. Key components of ADCs, including antibody formats, cleavable and noncleavable linkers, and cytotoxic payload classes such as auristatins, maytansinoids, duocarmycins, and topoisomerase inhibitors, are discussed in the context of optimizing the therapeutic index and tumor selectivity. Mechanistic aspects of ADC activity, including antigen-mediated internalization, intracellular trafficking, payload release, and the bystander effect, are highlighted for their relevance to heterogeneous CRC tumors. This review systematically summarizes emerging preclinical ADC candidates targeting CRC-associated antigens, including EGFR, CEACAM5, c-Met, RON, DDR1, GPR56, LGR5, Claudin-2, and CD98hc. Finally, key translational challenges—including antigen heterogeneity, limited internalization, and off-target toxicity—are discussed alongside future perspectives emphasizing biomarker-driven patient selection and rational ADC design. Graphical abstract The alternative text for this image may have been generated using AI.
- 28 May 2026
- Published by Springer Nature in Cancer Chemotherapy and Pharmacology
- Vol. 96 (1) , 58
Open AccessAntibody–drug conjugates in colorectal cancer: molecular design, preclinical advances, and translational challenges
Colorectal cancer (CRC) remains a leading cause of cancer-related morbidity and mortality worldwide, largely because of tumor heterogeneity, therapeutic resistance, and the limited efficacy of existing targeted therapies in advanced disease. Antibody–drug conjugates (ADCs) have emerged as a promising class of targeted anticancer therapeutics that combine the specificity of monoclonal antibodies with the cytotoxic potency of highly active payloads, thereby enabling selective tumor cell killing while minimizing systemic toxicity. Although ADCs have demonstrated substantial clinical success in several solid and hematological malignancies, their translation to CRC has been relatively limited, underscoring the need for a focused evaluation of CRC-specific ADC development. This review provides a comprehensive and critical overview of recent advances in ADC design and preclinical development for CRC, with emphasis on molecular architecture, linker–payload chemistry, antigen selection, and pharmacological mechanisms of action. Key components of ADCs, including antibody formats, cleavable and noncleavable linkers, and cytotoxic payload classes such as auristatins, maytansinoids, duocarmycins, and topoisomerase inhibitors, are discussed in the context of optimizing the therapeutic index and tumor selectivity. Mechanistic aspects of ADC activity, including antigen-mediated internalization, intracellular trafficking, payload release, and the bystander effect, are highlighted for their relevance to heterogeneous CRC tumors. This review systematically summarizes emerging preclinical ADC candidates targeting CRC-associated antigens, including EGFR, CEACAM5, c-Met, RON, DDR1, GPR56, LGR5, Claudin-2, and CD98hc. Finally, key translational challenges—including antigen heterogeneity, limited internalization, and off-target toxicity—are discussed alongside future perspectives emphasizing biomarker-driven patient selection and rational ADC design. Graphical abstract The alternative text for this image may have been generated using AI.
- Open Access
- 1 January 2026
- Published by Wiley in Journal of Toxicology
- Vol. 2026 (1)
Investigating the Protective Role of Folic Acid in Fluoride‐Induced Neurotoxicity: An Integrative Computational and In Vivo Study
Background: Excessive fluoride exposure has been associated with neurotoxicity, including cognitive deficits and an increased risk of dementia. SIRT1, a key regulator of oxidative stress, apoptosis, and inflammation, is downregulated in fluoride‐induced neurotoxicity. This study aimed to identify a potential nutraceutical compound that modulates SIRT1 and explore its effects in a rat model of fluoride‐induced neurotoxicity. Methods: Comprehensive computational approaches, including molecular docking, ADMET predictions, and molecular simulations, were employed. Rats were exposed to 50 ppm sodium fluoride (NaF) alone or cotreated with folic acid (FA; 2.5 or 5 mg/kg) for 8 weeks. NaF was provided in drinking water, and FA was administered via oral gavage. Neurotoxicity was assessed using behavioral paradigms (Morris water maze, novel object recognition test), along with the evaluation of SIRT1 levels, oxidative stress markers, apoptosis, inflammatory cytokines, acetylcholinesterase, and hippocampal histopathology. Results: Computational screening identified FA as a potential SIRT1 modulator. NaF treatment reduced brain SIRT1 levels ( p < 0.05) and was accompanied by increased oxidative stress, apoptosis, and inflammation, leading to learning and memory deficits. FA cotreatment mitigated these alterations, improving behavioral performance, preserving hippocampal structure, and restoring key biochemical markers. FA increased SIRT1, SOD, and Bcl2 levels, while reducing MDA, caspase 3, TNF‐ α , IL‐6, and AChE levels. Conclusion: FA may exert protective effects against fluoride‐induced neurotoxicity, potentially through SIRT1 activation and the modulation of oxidative stress, apoptosis, and inflammation. However, further in‐depth studies are needed to better understand its precise protective mechanisms and evaluate its translational relevance, particularly the extent to which SIRT1 activation contributes to these effects.
- 1 January 2026
- Published by Wiley in Journal of Toxicology
- Vol. 2026 (1)
Open AccessInvestigating the Protective Role of Folic Acid in Fluoride‐Induced Neurotoxicity: An Integrative Computational and In Vivo Study
Background: Excessive fluoride exposure has been associated with neurotoxicity, including cognitive deficits and an increased risk of dementia. SIRT1, a key regulator of oxidative stress, apoptosis, and inflammation, is downregulated in fluoride‐induced neurotoxicity. This study aimed to identify a potential nutraceutical compound that modulates SIRT1 and explore its effects in a rat model of fluoride‐induced neurotoxicity. Methods: Comprehensive computational approaches, including molecular docking, ADMET predictions, and molecular simulations, were employed. Rats were exposed to 50 ppm sodium fluoride (NaF) alone or cotreated with folic acid (FA; 2.5 or 5 mg/kg) for 8 weeks. NaF was provided in drinking water, and FA was administered via oral gavage. Neurotoxicity was assessed using behavioral paradigms (Morris water maze, novel object recognition test), along with the evaluation of SIRT1 levels, oxidative stress markers, apoptosis, inflammatory cytokines, acetylcholinesterase, and hippocampal histopathology. Results: Computational screening identified FA as a potential SIRT1 modulator. NaF treatment reduced brain SIRT1 levels ( p < 0.05) and was accompanied by increased oxidative stress, apoptosis, and inflammation, leading to learning and memory deficits. FA cotreatment mitigated these alterations, improving behavioral performance, preserving hippocampal structure, and restoring key biochemical markers. FA increased SIRT1, SOD, and Bcl2 levels, while reducing MDA, caspase 3, TNF‐ α , IL‐6, and AChE levels. Conclusion: FA may exert protective effects against fluoride‐induced neurotoxicity, potentially through SIRT1 activation and the modulation of oxidative stress, apoptosis, and inflammation. However, further in‐depth studies are needed to better understand its precise protective mechanisms and evaluate its translational relevance, particularly the extent to which SIRT1 activation contributes to these effects.
- 30 April 2025
- Published by Elsevier in Medical Journal Armed Forces India
- Vol. 82 (1) , 6-15
Exploring the therapeutic potential of beta-3 adrenergic agonists in overactive bladder: A comprehensive review
- 30 April 2025
- Published by Elsevier in Medical Journal Armed Forces India
- Vol. 82 (1) , 6-15
Exploring the therapeutic potential of beta-3 adrenergic agonists in overactive bladder: A comprehensive review
- Open Access
- 12 February 2025
- Published by Springer Nature in Schizophrenia
- Vol. 11 (1) , 1-15
Potential of extracellular vesicle cargo as molecular signals in Schizophrenia: a scoping review
The diagnosis of schizophrenia (SCZ) primarily relies on clinical history and mental status assessments by trained professionals. There has been a search for biomarkers to facilitate laboratory diagnosis. Since extracellular vesicles (EVs) communicate with brain cells and can easily cross blood-brain barrier, there is increased interest among experts to explore them as potential molecular signals for disease detection. A scoping review was conducted to provide a comprehensive summary of the existing literature to identify the differentially expressed molecular signals in EVs isolated from SCZ patients. The methodological framework outline provided by Arksey and O’Malley was employed to conduct this scoping review. A systematic search was conducted using a search string across four databases, ultimately leading to selection of 24 relevant studies. Over 1122 differentially expressed biomolecules were identified in EVs extracted from biological fluids and tissues that can be primarily categorized as RNAs, proteins, and metabolites. Among them, 83 biomolecules were identified as validated differentially expressed molecular signals, which included metabolites, circRNAs, lncRNAs, miRNAs, and proteins. These biomolecules were found to affect cellular receptors and intracellular pathways, neurotransmitters, mitochondrial functions, immune-related functions, and metabolic pathways, which could serve as potential biomarkers for SCZ diagnosis.
- 12 February 2025
- Published by Springer Nature in Schizophrenia
- Vol. 11 (1) , 1-15
Open AccessPotential of extracellular vesicle cargo as molecular signals in Schizophrenia: a scoping review
The diagnosis of schizophrenia (SCZ) primarily relies on clinical history and mental status assessments by trained professionals. There has been a search for biomarkers to facilitate laboratory diagnosis. Since extracellular vesicles (EVs) communicate with brain cells and can easily cross blood-brain barrier, there is increased interest among experts to explore them as potential molecular signals for disease detection. A scoping review was conducted to provide a comprehensive summary of the existing literature to identify the differentially expressed molecular signals in EVs isolated from SCZ patients. The methodological framework outline provided by Arksey and O’Malley was employed to conduct this scoping review. A systematic search was conducted using a search string across four databases, ultimately leading to selection of 24 relevant studies. Over 1122 differentially expressed biomolecules were identified in EVs extracted from biological fluids and tissues that can be primarily categorized as RNAs, proteins, and metabolites. Among them, 83 biomolecules were identified as validated differentially expressed molecular signals, which included metabolites, circRNAs, lncRNAs, miRNAs, and proteins. These biomolecules were found to affect cellular receptors and intracellular pathways, neurotransmitters, mitochondrial functions, immune-related functions, and metabolic pathways, which could serve as potential biomarkers for SCZ diagnosis.
- Open Access
- 22 October 2024
- Published by F1000 Research Ltd in F1000Research
- Vol. 13, 639
Kadukkai maathirai (Indian herbal drug) prevents hepatocellular cancer progression by enhancing GSTM1 expression and modulating β catenin transcription: in-silico and in-vivo study
Background Hepatocellular carcinoma (HCC) is an aggressive malignancy with poor clinical outcomes. Hence cost-effective drugs with fewer side effects as a standard supportive therapy might yield substantial advantages in efficacy and safety. Kadukkai maathirai (KM) is being used as a supplement in hepatocellular carcinoma. We evaluated whether KM has any preventive action on cancer progression in diethyl nitrosamine (DEN) - induced HCC in rats. Methods DEN was injected to produce HCC in rats, which was confirmed after 16 weeks. All the rats were orally administered KM for 4 weeks. Hepatoprotective potential (serum AST, ALT, ALP, Bilirubin) and anticancer efficacy (body weight, nodule count, tumor progression by histopathology, expression of GSTM1 by Liquid chromatography-mass spectrometry (LC-MS), and In-silico analysis of phytoconstituents against β catenin and LRP analysis were evaluated. Results KM prevented cancer progression against DEN-induced HCC by an increase in GSTM1, a phase II detoxifying enzyme. It significantly reversed altered nodule count, relative liver weight, body weight, and histopathological features of HCC. In silico analysis of phytoconstituents of KM showed that they modulate the intracellular transcription process by inhibiting the armadillo repeat region of β catenin. Conclusions Our results elucidate the potential of KM as a supplement in HCC by reducing nodule count, protecting the liver from further damage, GSTM1 expression, and inhibiting armadillo repeat region of β catenin.
- 22 October 2024
- Published by F1000 Research Ltd in F1000Research
- Vol. 13, 639
Open AccessKadukkai maathirai (Indian herbal drug) prevents hepatocellular cancer progression by enhancing GSTM1 expression and modulating β catenin transcription: in-silico and in-vivo study
Background Hepatocellular carcinoma (HCC) is an aggressive malignancy with poor clinical outcomes. Hence cost-effective drugs with fewer side effects as a standard supportive therapy might yield substantial advantages in efficacy and safety. Kadukkai maathirai (KM) is being used as a supplement in hepatocellular carcinoma. We evaluated whether KM has any preventive action on cancer progression in diethyl nitrosamine (DEN) - induced HCC in rats. Methods DEN was injected to produce HCC in rats, which was confirmed after 16 weeks. All the rats were orally administered KM for 4 weeks. Hepatoprotective potential (serum AST, ALT, ALP, Bilirubin) and anticancer efficacy (body weight, nodule count, tumor progression by histopathology, expression of GSTM1 by Liquid chromatography-mass spectrometry (LC-MS), and In-silico analysis of phytoconstituents against β catenin and LRP analysis were evaluated. Results KM prevented cancer progression against DEN-induced HCC by an increase in GSTM1, a phase II detoxifying enzyme. It significantly reversed altered nodule count, relative liver weight, body weight, and histopathological features of HCC. In silico analysis of phytoconstituents of KM showed that they modulate the intracellular transcription process by inhibiting the armadillo repeat region of β catenin. Conclusions Our results elucidate the potential of KM as a supplement in HCC by reducing nodule count, protecting the liver from further damage, GSTM1 expression, and inhibiting armadillo repeat region of β catenin.
- Open Access
- 30 September 2024
- Published by Oriental Scientific Publishing Company in Biomedical and Pharmacology Journal
- Vol. 17 (3) , 1727-1738
Role of Hydroalcoholic Extracts of Aegle marmelos (AM) Leaves and Tamarindus indica (TI) Seeds on High Fat High Sugar Diet Induced Hyperlipidemia in Rodent Models
Hyperlipidemia is an increase in plasma levels of lipids (cholesterol, triglycerides) and various lipoproteins. Though many drugs have been used for controlling hyperlipidemia, yet most of them have unpleasant side effects, which has stimulated the search for natural remedies. Hypolipidemic activity of hydroalcoholic extracts of Aegle marmelos (AM) leaves and Tamarindus indica (TI) seed alone and in combination on High Fat High Sugar (Fructose) Diet (HFHSD) induced hyperlipidemia in male rats was evaluated in this study. Out of 54 male Sprague Dawley rats, six received standard diet (Group I, normal control) throughout the study. The remaining 48 rats were fed orally with HFHSD for 30 days to induce hyperlipidemia (plasma cholesterol level >200 mg/dL). For the next thirty days, rats which had received HFHSD were divided into 8 groups with six animals in each. Group II- HFHSD control received standard diet, Group III- positive control (Niacin, 100 mg/kg/day), Group IV - AM25 (25 mg/kg/day), Group V - AM50 (50 mg/kg/day), Group VI - TI25 (25 mg/kg/day), Group VII - TI50 (50mg/kg/day), Groups VIII - AM25+TI25 (25 + 25 mg/kg/day) and Group IX - AM50+TI50 (50 + 50 mg/kg/day). Treatment of HFHSD fed rats with each extract alone and in combination resulted in a significant decrease in plasma cholesterol, triglycerides, LDL and VLDL and increase in HDL levels. Treatment with AM50+TI50 significantly lowered plasma cholesterol (p<0.001), triglycerides (p<0.001) and increased HDL cholesterol levels (p<0.05), in comparison to positive control. Both the extracts alone and in combination exerted hypolipidemic effect in rats.
- 30 September 2024
- Published by Oriental Scientific Publishing Company in Biomedical and Pharmacology Journal
- Vol. 17 (3) , 1727-1738
Open AccessRole of Hydroalcoholic Extracts of Aegle marmelos (AM) Leaves and Tamarindus indica (TI) Seeds on High Fat High Sugar Diet Induced Hyperlipidemia in Rodent Models
Hyperlipidemia is an increase in plasma levels of lipids (cholesterol, triglycerides) and various lipoproteins. Though many drugs have been used for controlling hyperlipidemia, yet most of them have unpleasant side effects, which has stimulated the search for natural remedies. Hypolipidemic activity of hydroalcoholic extracts of Aegle marmelos (AM) leaves and Tamarindus indica (TI) seed alone and in combination on High Fat High Sugar (Fructose) Diet (HFHSD) induced hyperlipidemia in male rats was evaluated in this study. Out of 54 male Sprague Dawley rats, six received standard diet (Group I, normal control) throughout the study. The remaining 48 rats were fed orally with HFHSD for 30 days to induce hyperlipidemia (plasma cholesterol level >200 mg/dL). For the next thirty days, rats which had received HFHSD were divided into 8 groups with six animals in each. Group II- HFHSD control received standard diet, Group III- positive control (Niacin, 100 mg/kg/day), Group IV - AM25 (25 mg/kg/day), Group V - AM50 (50 mg/kg/day), Group VI - TI25 (25 mg/kg/day), Group VII - TI50 (50mg/kg/day), Groups VIII - AM25+TI25 (25 + 25 mg/kg/day) and Group IX - AM50+TI50 (50 + 50 mg/kg/day). Treatment of HFHSD fed rats with each extract alone and in combination resulted in a significant decrease in plasma cholesterol, triglycerides, LDL and VLDL and increase in HDL levels. Treatment with AM50+TI50 significantly lowered plasma cholesterol (p<0.001), triglycerides (p<0.001) and increased HDL cholesterol levels (p<0.05), in comparison to positive control. Both the extracts alone and in combination exerted hypolipidemic effect in rats.
- Open Access
- 17 June 2024
- Published by F1000 Research Ltd in F1000Research
- Vol. 13, 639
Kadukkai maathirai (Indian herbal drug) prevents hepatocellular cancer progression by enhancing GSTM1 expression and modulating β catenin transcription: in-silico and in-vivo study
Background Hepatocellular carcinoma (HCC) is an aggressive malignancy with poor clinical outcomes. Hence cost-effective drugs with fewer side effects as a standard supportive therapy might yield substantial advantages in efficacy and safety. Kadukkai maathirai (KM) is being used as a supplement in hepatocellular carcinoma. We evaluated whether KM has any preventive action on cancer progression in diethyl nitrosamine (DEN) - induced HCC in rats. Methods DEN was injected to produce HCC in rats, which was confirmed after 16 weeks. All the rats were orally administered KM for 4 weeks. Hepatoprotective potential (serum AST, ALT, ALP, Bilirubin) and anticancer efficacy (body weight, nodule count, tumor progression by histopathology, expression of GSTM1 by Liquid chromatography-mass spectrometry (LC-MS), and In-silico analysis of phytoconstituents against β catenin and LRP analysis were evaluated. Results KM prevented cancer progression against DEN-induced HCC by an increase in GSTM1, a phase II detoxifying enzyme. It significantly reversed altered nodule count, relative liver weight, body weight, and histopathological features of HCC. In silico analysis of phytoconstituents of KM showed that they modulate the intracellular transcription process by inhibiting the armadillo repeat region of β catenin. Conclusions Our results elucidate the potential of KM as a supplement in HCC by reducing nodule count, protecting the liver from further damage, GSTM1 expression, and inhibiting armadillo repeat region of β catenin.
- 17 June 2024
- Published by F1000 Research Ltd in F1000Research
- Vol. 13, 639
Open AccessKadukkai maathirai (Indian herbal drug) prevents hepatocellular cancer progression by enhancing GSTM1 expression and modulating β catenin transcription: in-silico and in-vivo study
Background Hepatocellular carcinoma (HCC) is an aggressive malignancy with poor clinical outcomes. Hence cost-effective drugs with fewer side effects as a standard supportive therapy might yield substantial advantages in efficacy and safety. Kadukkai maathirai (KM) is being used as a supplement in hepatocellular carcinoma. We evaluated whether KM has any preventive action on cancer progression in diethyl nitrosamine (DEN) - induced HCC in rats. Methods DEN was injected to produce HCC in rats, which was confirmed after 16 weeks. All the rats were orally administered KM for 4 weeks. Hepatoprotective potential (serum AST, ALT, ALP, Bilirubin) and anticancer efficacy (body weight, nodule count, tumor progression by histopathology, expression of GSTM1 by Liquid chromatography-mass spectrometry (LC-MS), and In-silico analysis of phytoconstituents against β catenin and LRP analysis were evaluated. Results KM prevented cancer progression against DEN-induced HCC by an increase in GSTM1, a phase II detoxifying enzyme. It significantly reversed altered nodule count, relative liver weight, body weight, and histopathological features of HCC. In silico analysis of phytoconstituents of KM showed that they modulate the intracellular transcription process by inhibiting the armadillo repeat region of β catenin. Conclusions Our results elucidate the potential of KM as a supplement in HCC by reducing nodule count, protecting the liver from further damage, GSTM1 expression, and inhibiting armadillo repeat region of β catenin.
- Open Access
- 28 February 2024
- Published by Springer Nature in Biological Trace Element Research
- Vol. 202 (12) , 5395-5412
Role of SIRT1 in Potentially Toxic Trace Elements (Lead, Fluoride, Aluminum and Cadmium) Associated Neurodevelopmental Toxicity
The formation of the central nervous system is a meticulously planned and intricate process. Any modification to this process has the potential to disrupt the structure and operation of the brain, which could result in deficiencies in neurological growth. When neurotoxic substances are present during the early stages of development, they can be exceptionally dangerous. Prenatally, the immature brain is extremely vulnerable and is therefore at high risk in pregnant women associated with occupational exposures. Lead, fluoride, aluminum, and cadmium are examples of possibly toxic trace elements that have been identified as an environmental concern in the aetiology of a number of neurological and neurodegenerative illnesses. SIRT1, a member of the sirtuin family has received most attention for its potential neuroprotective properties. SIRT1 is an intriguing therapeutic target since it demonstrates important functions to increase neurogenesis and cellular lifespan by modulating multiple pathways. It promotes axonal extension, neurite growth, and dendritic branching during the development of neurons. Additionally, it contributes to neurogenesis, synaptic plasticity, memory development, and neuroprotection. This review summarizes the possible role of SIRT1 signalling pathway in potentially toxic trace elements -induced neurodevelopmental toxicity, highlighting some molecular pathways such as mitochondrial biogenesis, CREB/BDNF and PGC-1α/NRF1/TFAM.
- 28 February 2024
- Published by Springer Nature in Biological Trace Element Research
- Vol. 202 (12) , 5395-5412
Open AccessRole of SIRT1 in Potentially Toxic Trace Elements (Lead, Fluoride, Aluminum and Cadmium) Associated Neurodevelopmental Toxicity
The formation of the central nervous system is a meticulously planned and intricate process. Any modification to this process has the potential to disrupt the structure and operation of the brain, which could result in deficiencies in neurological growth. When neurotoxic substances are present during the early stages of development, they can be exceptionally dangerous. Prenatally, the immature brain is extremely vulnerable and is therefore at high risk in pregnant women associated with occupational exposures. Lead, fluoride, aluminum, and cadmium are examples of possibly toxic trace elements that have been identified as an environmental concern in the aetiology of a number of neurological and neurodegenerative illnesses. SIRT1, a member of the sirtuin family has received most attention for its potential neuroprotective properties. SIRT1 is an intriguing therapeutic target since it demonstrates important functions to increase neurogenesis and cellular lifespan by modulating multiple pathways. It promotes axonal extension, neurite growth, and dendritic branching during the development of neurons. Additionally, it contributes to neurogenesis, synaptic plasticity, memory development, and neuroprotection. This review summarizes the possible role of SIRT1 signalling pathway in potentially toxic trace elements -induced neurodevelopmental toxicity, highlighting some molecular pathways such as mitochondrial biogenesis, CREB/BDNF and PGC-1α/NRF1/TFAM.
- Open Access
- 1 February 2024
- Published by Informatics Publishing Limited in Journal of Natural Remedies
- p. 311-322
Sinapis alba ln Status Epilepticus: A Preclinical Study
In this study, the anti-convulsant effect of Sinapis alba seed oil and its combination with sodium valproate was evaluated in Wistar albino rats using the lithium-pilocarpine Status Epilepticus (SE) model. The experimental groups included: Group I - normal control; Group II - disease control; Group III - Sinapis alba seed oil; Group IV - sodium valproate; Group V - Sinapis alba seed oil + ½ dose sodium valproate. Antioxidant markers and Brain-Derived Neurotrophic Factor (BDNF) levels were measured from the brain samples. The pathological changes were also determined using Cresyl violet staining. Sinapis alba oil did not prevent rats from developing status epilepticus but reduced the intensity and frequency of occurrence. Oil administration increased antioxidant levels and decreased lipid peroxide levels as well. The combination of oil and sodium valproate showed a synergistic effect in the status epilepticus model. The study results show that Sinapis alba can be used as an adjuvant in status epilepticus along with other antiepileptic drugs.
- 1 February 2024
- Published by Informatics Publishing Limited in Journal of Natural Remedies
- p. 311-322
Open AccessSinapis alba ln Status Epilepticus: A Preclinical Study
In this study, the anti-convulsant effect of Sinapis alba seed oil and its combination with sodium valproate was evaluated in Wistar albino rats using the lithium-pilocarpine Status Epilepticus (SE) model. The experimental groups included: Group I - normal control; Group II - disease control; Group III - Sinapis alba seed oil; Group IV - sodium valproate; Group V - Sinapis alba seed oil + ½ dose sodium valproate. Antioxidant markers and Brain-Derived Neurotrophic Factor (BDNF) levels were measured from the brain samples. The pathological changes were also determined using Cresyl violet staining. Sinapis alba oil did not prevent rats from developing status epilepticus but reduced the intensity and frequency of occurrence. Oil administration increased antioxidant levels and decreased lipid peroxide levels as well. The combination of oil and sodium valproate showed a synergistic effect in the status epilepticus model. The study results show that Sinapis alba can be used as an adjuvant in status epilepticus along with other antiepileptic drugs.